Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Global death toll from COVID hits 6 million, and WHO warns pandemic is not yet over
11:47am, Tuesday, 08'th Mar 2022 MarketWatch
The global death toll from COVID-19 hit 6 million early Monday, according to data aggregated by Johns Hopkins University, underscoring that the pandemic, now entering its third year, is far from over.
Could Inovio Win On This 1 Vaccine Detail?
11:00am, Tuesday, 08'th Mar 2022 The Motley Fool
This vaccine laggard suffered a new setback -- but there is one piece of good news.
Moderna signs MOU with Kenya for first mRNA facility in Africa
10:08am, Tuesday, 08'th Mar 2022 Al Jazeera
Moderna says it signed an MOU with Kenya for its first mRNA vaccine manufacturing facility in Africa.
Moderna aims to explore vaccines against 15 pathogens threatening global health
09:33am, Tuesday, 08'th Mar 2022 Seeking Alpha
Moderna (MRNA) has committed to advance vaccines targeting 15 pathogens considered as biggest public health risk by the WHO and CEPI into clinical studies by 2025.The company expects…
Moderna to build the first COVID vaccine plant in Africa for Ksh60 billion in Kenya
08:12am, Tuesday, 08'th Mar 2022 Kenya Satellite Network
By Judith Gicobi Kenya has made an agreement with Moderna to build the company’s first production facility in Africa. Susan Mochache, the Principal Secretary of Health, released a statement on Monday. President Uhuru Kenyatta said Kenya is “pleased to partner with Moderna in the establishment of this mRNA manufacturing facility to help prepare the country […]
Moderna To Build Ksh57B State Of The Art Vaccine Facility In Kenya
03:49am, Tuesday, 08'th Mar 2022 Nairobi Wire
President Uhuru Kenyatta on Monday witnessed the signing of a memorandum of understanding between Kenya and Moderna to establish the first mRNA manufacturing facility in Africa. The state-of-the-art mRNA facility in Africa is expected to produce up to 500 million doses of vaccines each year. The Company anticipates investing up to $500 million in the […]
Covid-19: Moderna to develop vaccines against 15 pathogens with future pandemic potential
03:37am, Tuesday, 08'th Mar 2022 Khaleej Times
''The 15 viruses are known threats that have not been addressed by many large drugmakers''
Moderna will enforce vaccine patents in wealthy countries - WSJ (NASDAQ:MRNA)
01:35am, Tuesday, 08'th Mar 2022 Seeking Alpha
Moderna (MRNA) said that it will enforce its patents in wealthier countries where other companies want to utilize its technologies, The Wall Street Journal reports.
Covid vaccines not linked to deaths, major US study finds
01:17am, Tuesday, 08'th Mar 2022 BBC UK
The CDC says 92% of reported side effects after the Pfizer and Moderna vaccines are mild.
Modera hints it may enforce COVID vaccine patents in wealthy countries
01:13am, Tuesday, 08'th Mar 2022 MarketWatch
Moderna Inc. said it will never use its COVID-19 vaccine-related patents to stop others from manufacturing its vaccine in more than 90 low- and middle-income countries, but signaled it was prepared
Moderna Signals It May Enforce Covid-19 Vaccine Patents in Wealthy Nations
12:33am, Tuesday, 08'th Mar 2022 The Wall Street Journal
The drugmaker says it won’t stop anyone from making its shots in low- and middle-income nations and would license the technology elsewhere.
Moderna Commits to Design and Test 15 Vaccines That Could Tackle Next Pandemic
12:01am, Tuesday, 08'th Mar 2022 Barron''s
The biotech will seek partners, but said it would develop the vaccines on its own for any diseases for which it doesn’t find someone to work with.
Why Moderna Stock Was Sick on Monday
10:48pm, Monday, 07'th Mar 2022 The Motley Fool
An analyst from a prominent investment bank shaves $20 off his price target on the shares.
Ocugen (OCGN) Down 23% With FDA Denial of COVID Vaccine EUA
10:27pm, Monday, 07'th Mar 2022 Zacks Investment Research
The FDA turns down an emergency use authorization request from Ocugen (OCGN) to use its COVID-19 vaccine Covaxin in pediatric population. Stock depreciates.
News24.com | Moderna announces first African vaccine facility in Kenya
07:48pm, Monday, 07'th Mar 2022 News24
US vaccine maker Moderna announced Monday that it would build its first mRNA jab-manufacturing facility in Africa after signing an agreement with Kenya''s government to produce up to 500 million doses a year.
